Compare AFL & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFL | COR |
|---|---|---|
| Founded | 1955 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.0B | 57.4B |
| IPO Year | N/A | N/A |
| Metric | AFL | COR |
|---|---|---|
| Price | $109.26 | $353.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $110.42 | ★ $360.62 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.23% | 0.68% |
| EPS Growth | ★ 15.49 | 5.71 |
| EPS | 7.68 | ★ 7.96 |
| Revenue | $17,701,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | N/A | $7.17 |
| Revenue Next Year | $0.91 | $6.57 |
| P/E Ratio | ★ $14.27 | $44.64 |
| Revenue Growth | 2.31 | ★ 9.31 |
| 52 Week Low | $96.95 | $236.37 |
| 52 Week High | $115.84 | $377.54 |
| Indicator | AFL | COR |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 61.28 |
| Support Level | $107.36 | $333.79 |
| Resistance Level | $110.81 | $349.55 |
| Average True Range (ATR) | 1.68 | 6.91 |
| MACD | -0.14 | 1.98 |
| Stochastic Oscillator | 33.09 | 89.43 |
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.